Johnson & Johnson (JNJ) Earnings Analysis

Johnson & Johnson (JNJ) next reports earnings on 2026-10-13, consensus EPS 3.04 USD. Last quarter (2026-07-15) it beat with EPS 2.9 USD vs 2.84 USD est (+2.1%). It has beaten estimates in 8/8 recent quarters (100%). Trailing P/E 29.55.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does JNJ next report earnings?

Next earnings date2026-10-13
Consensus EPS estimate3.04 USD
Revenue estimate25.32B

JNJ earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-07-152.9 USD2.84 USD+2.1%Beat
2026-04-142.7 USD2.68 USD+0.7%Beat
2026-01-212.46 USD2.46 USD0%Beat
2025-10-142.8 USD2.76 USD+1.4%Beat
2025-07-162.77 USD2.68 USD+3.4%Beat
2025-04-152.77 USD2.58 USD+7.4%Beat
2025-01-222.04 USD1.99 USD+2.5%Beat
2024-10-152.42 USD2.21 USD+9.5%Beat

Beat rate: 8/8 (100%) over reported quarters with consensus data.

JNJ valuation and analyst view

Trailing P/E29.55
Trailing EPS8.621 USD
Price / book7.68
Dividend yield2.05%
Market cap614.32B
Analyst consensusBuy (21 buy / 16 hold / 3 sell)
Avg price target277.5 USD

Related research pages

Frequently asked questions

When is Johnson & Johnson (JNJ)'s next earnings date?

Johnson & Johnson is next scheduled to report on 2026-10-13, with a consensus EPS estimate of 3.04 USD and revenue estimate of 25.32B.

Did JNJ beat earnings last quarter?

In its 2026-07-15 report, JNJ posted EPS of 2.9 USD versus a 2.84 USD estimate — a beat of 2.1%.

What is JNJ's earnings track record?

Over the last 8 reported quarters with consensus data, JNJ beat estimates 8 times (100%).

What is JNJ's current P/E ratio and EPS?

JNJ trades at a trailing P/E of 29.55 on trailing EPS of 8.621216051682216 USD.

What do analysts rate JNJ?

Analyst consensus is "Buy" across 40 ratings (0 strong buy, 21 buy, 16 hold, 3 sell, 0 strong sell). Average 12-month price target: 277.5 USD.